Direct measurement of pancreatic enzymes

A comparison of secretagogues

Marian Pfefferkorn, Joseph F. Fitzgerald, Joseph Croffie, Sandeep Gupta, Helena M. Caffrey

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Direct measurement of pancreatic enzymes is the gold standard in the evaluation of exocrine pancreatic function. The purpose of our study was to evaluate the use of cholecystokinin as a single-agent secretagogue for pancreatic drainage studies. Twenty pediatric patients received cholecystokinin (group 1) and 40 patients received either secretin plus placebo (group 2) or secretin plus cholecystokinin (group 3). Duodenal fluid was collected for measurement of lipase, amylase, trypsin, chymotrypsin. The mean lipase and amylase activities were higher in group 3 and the mean trypsin and chymotrypsin activities were higher in group 1, but none of these observations were statistically significant. Group 3 had more patients with all four enzymes being normal (75%) compared to groups 1 (60%) and 2 (50%) (P = 0.262). Patients in all three groups had at least one normal enzyme. Cholecystokinin is useful as a single agent for direct pancreatic enzyme measurements in the absence of commercially available secretin.

Original languageEnglish
Pages (from-to)2211-2216
Number of pages6
JournalDigestive Diseases and Sciences
Volume47
Issue number10
DOIs
StatePublished - Oct 1 2002

Fingerprint

Cholecystokinin
Secretin
Enzymes
Amylases
Lipase
Drainage
Placebos
Pediatrics
trypsin drug combination chymotrypsin

Keywords

  • Exocrine pancreas
  • Lipase
  • Pancreatic enzymes

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Direct measurement of pancreatic enzymes : A comparison of secretagogues. / Pfefferkorn, Marian; Fitzgerald, Joseph F.; Croffie, Joseph; Gupta, Sandeep; Caffrey, Helena M.

In: Digestive Diseases and Sciences, Vol. 47, No. 10, 01.10.2002, p. 2211-2216.

Research output: Contribution to journalArticle

@article{fe8e56e3e4c84076974fa15611e9807a,
title = "Direct measurement of pancreatic enzymes: A comparison of secretagogues",
abstract = "Direct measurement of pancreatic enzymes is the gold standard in the evaluation of exocrine pancreatic function. The purpose of our study was to evaluate the use of cholecystokinin as a single-agent secretagogue for pancreatic drainage studies. Twenty pediatric patients received cholecystokinin (group 1) and 40 patients received either secretin plus placebo (group 2) or secretin plus cholecystokinin (group 3). Duodenal fluid was collected for measurement of lipase, amylase, trypsin, chymotrypsin. The mean lipase and amylase activities were higher in group 3 and the mean trypsin and chymotrypsin activities were higher in group 1, but none of these observations were statistically significant. Group 3 had more patients with all four enzymes being normal (75{\%}) compared to groups 1 (60{\%}) and 2 (50{\%}) (P = 0.262). Patients in all three groups had at least one normal enzyme. Cholecystokinin is useful as a single agent for direct pancreatic enzyme measurements in the absence of commercially available secretin.",
keywords = "Exocrine pancreas, Lipase, Pancreatic enzymes",
author = "Marian Pfefferkorn and Fitzgerald, {Joseph F.} and Joseph Croffie and Sandeep Gupta and Caffrey, {Helena M.}",
year = "2002",
month = "10",
day = "1",
doi = "10.1023/A:1020127025489",
language = "English",
volume = "47",
pages = "2211--2216",
journal = "Digestive Diseases and Sciences",
issn = "0163-2116",
publisher = "Springer New York",
number = "10",

}

TY - JOUR

T1 - Direct measurement of pancreatic enzymes

T2 - A comparison of secretagogues

AU - Pfefferkorn, Marian

AU - Fitzgerald, Joseph F.

AU - Croffie, Joseph

AU - Gupta, Sandeep

AU - Caffrey, Helena M.

PY - 2002/10/1

Y1 - 2002/10/1

N2 - Direct measurement of pancreatic enzymes is the gold standard in the evaluation of exocrine pancreatic function. The purpose of our study was to evaluate the use of cholecystokinin as a single-agent secretagogue for pancreatic drainage studies. Twenty pediatric patients received cholecystokinin (group 1) and 40 patients received either secretin plus placebo (group 2) or secretin plus cholecystokinin (group 3). Duodenal fluid was collected for measurement of lipase, amylase, trypsin, chymotrypsin. The mean lipase and amylase activities were higher in group 3 and the mean trypsin and chymotrypsin activities were higher in group 1, but none of these observations were statistically significant. Group 3 had more patients with all four enzymes being normal (75%) compared to groups 1 (60%) and 2 (50%) (P = 0.262). Patients in all three groups had at least one normal enzyme. Cholecystokinin is useful as a single agent for direct pancreatic enzyme measurements in the absence of commercially available secretin.

AB - Direct measurement of pancreatic enzymes is the gold standard in the evaluation of exocrine pancreatic function. The purpose of our study was to evaluate the use of cholecystokinin as a single-agent secretagogue for pancreatic drainage studies. Twenty pediatric patients received cholecystokinin (group 1) and 40 patients received either secretin plus placebo (group 2) or secretin plus cholecystokinin (group 3). Duodenal fluid was collected for measurement of lipase, amylase, trypsin, chymotrypsin. The mean lipase and amylase activities were higher in group 3 and the mean trypsin and chymotrypsin activities were higher in group 1, but none of these observations were statistically significant. Group 3 had more patients with all four enzymes being normal (75%) compared to groups 1 (60%) and 2 (50%) (P = 0.262). Patients in all three groups had at least one normal enzyme. Cholecystokinin is useful as a single agent for direct pancreatic enzyme measurements in the absence of commercially available secretin.

KW - Exocrine pancreas

KW - Lipase

KW - Pancreatic enzymes

UR - http://www.scopus.com/inward/record.url?scp=0036796964&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036796964&partnerID=8YFLogxK

U2 - 10.1023/A:1020127025489

DO - 10.1023/A:1020127025489

M3 - Article

VL - 47

SP - 2211

EP - 2216

JO - Digestive Diseases and Sciences

JF - Digestive Diseases and Sciences

SN - 0163-2116

IS - 10

ER -